Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001590934-17-000001
Filing Date
2017-05-15
Accepted
2017-05-15 13:15:40
Documents
1
Effectiveness Date
2017-05-15
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 6367
  Complete submission text file 0001590934-17-000001.txt   7382
Mailing Address 474 39TH AVENUE EAST SEATTLE WA 98112
Business Address 474 39TH AVENUE EAST SEATTLE WA 98112 206-322-7526
Oricula Therapeutics LLC (Filer) CIK: 0001590934 (see all company filings)

EIN.: 461984834 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-286733 | Film No.: 17842892